BSX 6.06 -0.04 / Boston Scientific Corp. FDA | Benzinga

Friday, May 18, 2012

Boston Scientific: PROMUS Element Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study (BSX, News, FDA / Fri, 06:32am)

Thursday, May 17, 2012

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC Vascular Stent (BSX, News, FDA / Thu, 05:16pm)

Tuesday, May 15, 2012

Boston Scientific Announces Positive Data from Lotus Transcatheter Aortic Valve Trial (BSX, News, FDA / Tue, 12:46pm)
Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial (BSX, News, FDA / Tue, 11:00am)

Monday, May 14, 2012

Boston Scientific Announces CE Mark and European Launch of Innova™ Self-expanding Bare-metal Stent System (BSX, News, FDA, Global / Mon, 09:02am)

Friday, May 11, 2012

BSX: WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation (BSX, News, FDA / Fri, 08:03am)

Monday, May 07, 2012

Boston Scientific Announces FDA Approval and First U.S. Implant of New Devices To Treat Bradycardia (BSX, News, FDA / Mon, 08:31am)

Tuesday, April 24, 2012

Boston Scientific Announces CE Mark and European Launch of Emerge PTCA Dilatation Catheter (BSX, News, FDA, Global / Tue, 08:30am)

Monday, April 23, 2012

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus Aortic Valve System (BSX, News, FDA / Mon, 08:30am)

Wednesday, April 11, 2012

Boston Scientific Announces U.S. Launch of Z Flex-270 Steerable Sheath (BSX, News, FDA / Wed, 08:32am)

Tuesday, April 10, 2012

Boston Scientific Announces Launch of INGENIO Family of Pacemakers in Europe (BSX, News, FDA, Global / Tue, 08:31am)

Monday, April 02, 2012

Boston Scientific Marketing Backstop Gel in US (BSX, News, FDA / Mon, 08:35am)

Tuesday, March 27, 2012

Boston Scientific: Alair Systems Meets CTAF Criteria (BSX, News, Contracts, FDA / Tue, 08:33am)

Monday, March 26, 2012

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients (BSX, MDCO, News, FDA / Mon, 08:36am)

Thursday, March 22, 2012

Boston Scientific Begins U.S. and International Launch of WallFlex Biliary Transhepatic Stent System (BSX, News, FDA / Thu, 08:36am)

Thursday, March 08, 2012

Boston Scientific Renews Agreement with Lumenis to Deliver Innovative Laser Products to Treat Urologic Conditions (BSX, News, Contracts, FDA / Thu, 09:31am)

Thursday, March 01, 2012

Boston Scientific Announces Launch of PROMUS Element Platinum Chromium Stent System in Japan (BSX, News, FDA / Thu, 09:33am)

Thursday, February 23, 2012

Boston Scientific Announces First Implants of TELIGEN Implantable Defibrillator in China (BSX, News, FDA / Thu, 09:31am)

Wednesday, February 22, 2012

Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients (BSX, DES, News, FDA / Wed, 06:01pm)

Tuesday, February 07, 2012

Boston Scientific WallFlex Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries (BSX, News, FDA / Tue, 09:30am)

Monday, February 06, 2012

Boston Scientific Announces Global Launch of Expect 19 Flex Endoscopic Ultrasound Aspiration Needle (BSX, FNA, News, Contracts, FDA / Mon, 09:31am)

Wednesday, February 01, 2012

Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe (BSX, News, FDA, Global / Wed, 09:32am)

Monday, January 23, 2012

Boston Scientific Announces Favorable Ruling in Patent Infringement Case (BSX, News, FDA, Legal / Mon, 09:31am)

Tuesday, January 17, 2012

From Earlier: Boston Scientific Epic Stent Demonstrates Positive Clinical Outcomes in Orion Trial (BSX, News, FDA / Tue, 08:10am)

Wednesday, January 04, 2012

Boston Scientific's Alair Bronchial Thermoplasty System Achieves Important Reimbursement Milestones (BSX, News, FDA / Wed, 08:33am)
Boston Scientific's Alair Bronchial Thermoplasty System Achieves Important Reimbursement Milestones (BSX, News, FDA / Wed, 08:31am)

Thursday, December 08, 2011

Boston Scientific Receives FDA Approval for New Infinion 16 Percutaneous Lead for Precision Plus Spinal Cord Stimulator System (BSX, News, FDA / Thu, 09:31am)

Wednesday, November 30, 2011

Boston Scientific Announces FDA Approval and First Implant for New Devices to Treat Heart Failure and Sudden Cardiac Death (BSX, News, FDA / Wed, 09:31am)

Wednesday, November 23, 2011

UPDATE: Citi Lowers PT to $5.70 on Boston Scientific (Analyst Color, BSX, News, Price Target, FDA, Analyst Ratings / Wed, 11:05am)
Goldman Sachs Maintains Neutral Rating and $5.80 PT on Boston Scientific (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 10:14am)
Morgan Stanley Reiterates Equal-Weight on Boston Scientific (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:54am)
Bank of America Maintains Neutral Rating and $8.50 PT on Boston Scientific (Analyst Color, BSX, LSC, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:51am)
Brean Murray Carret & Co Maintains Hold Rating on Boston Scientific (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:44am)
UPDATE: Piper Jaffray Reiterates Neutral, Ups Target to $7 on Boston Scientific (Analyst Color, BSX, News, Price Target, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 08:18am)
FDA Approves PROMUS for Boston Scientific, Deutsche Bank Maintains Hold (Analyst Color, BSX, News, Reiteration, FDA, Pre-Market Outlook, Analyst Ratings / Wed, 07:23am)

Wednesday, November 16, 2011

Boston Scientific's WATCHMAN Device Implanted in First Patients in Latin America (BSX, News, FDA / Wed, 09:30am)